Literature DB >> 28149146

Antifungal Susceptibility and Risk Factors in Patients with Candidemia.

Cigdem Mermutluoglu1, Ozcan Deveci2, Saim Dayan2, Emel Aslan2, Fatma Bozkurt2, Recep Tekin2.   

Abstract

OBJECTIVE: This study aimed to investigate the antifungal susceptibility, typology, and risk factors of candidemia among adult and pediatric inpatients at a university hospital.
MATERIALS AND METHODS: A case-control study was designed, and data collected between December 2013 and December 2014 were retrospectively evaluated. The case group consisted of patients with candidemia. The control group was selected from the inpatients that did not develop candidemia but were admitted in the same clinic and during the same period as the candidemia group. The diagnosis of candidemia was based on a compatible clinical picture and positive blood culture of Candida spp. The demographic characteristics, sequential organ failure assessment (SOFA) scores, comorbidities, use of invasive devices, antibiotics administered, and duration of antibiotic uses were compared between both the groups.
RESULTS: Out of the 84 patients, 42 (50%) were included in the case group, and the remaining 42 (50%) were included in the control group. Out of all the patients, 31 (36.9%) were female, and 53 (63.1%) were male. When the clinical findings of the case and control groups were compared, the prevalence of nosocomial infections, sepsis, candiduria, and fever was statistically significantly higher in the case group. Among the isolated group in the study, 22 (52.4%) were identified as C. albicans, while the others were non-albicans Candida strains. The C. albicans strain (4.5%) was resistant to fluconazole, while 7 among the non-albicans Candida strains (35%) were resistant to fluconazole. In the case group, abdominal surgery, CVP catheter presence, TPN, endotracheal intubation, frequency of blood transfusion, and SOFA scores were significantly higher than the control groups. The logistic regression test demonstrated that TPN and blood transfusion are the most important risk factors for candidemia (OR=8.14 and OR=5.96, respectively).
CONCLUSION: The invasive Candida infections continue to be a major health problem in Turkey and in our hospital. Particularly, it was observed that it is important to perform invasive procedures, antibiotic administration and parenteral nutrition carefully in patients hospitalized in the ICU.

Entities:  

Keywords:  Candidemia; antifungal susceptibility; risk factors

Year:  2016        PMID: 28149146      PMCID: PMC5268603          DOI: 10.5152/eurasianmed.2016.0021

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  23 in total

1.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.

Authors:  H M Blumberg; W R Jarvis; J M Soucie; J E Edwards; J E Patterson; M A Pfaller; M S Rangel-Frausto; M G Rinaldi; L Saiman; R T Wiblin; R P Wenzel
Journal:  Clin Infect Dis       Date:  2001-06-20       Impact factor: 9.079

2.  Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decades.

Authors:  Amar Safdar; David S Perlin; Donald Armstrong
Journal:  Diagn Microbiol Infect Dis       Date:  2002-09       Impact factor: 2.803

3.  Prevalence of fungal species in patients with funguria.

Authors:  B R Mirdha; S Sethi; U Banerjee
Journal:  Indian J Med Res       Date:  1998-02       Impact factor: 2.375

Review 4.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

6.  Investigation of Candida dubliniensis in Candida spp.-positive hemocultures.

Authors:  Istar Dolapci; Alper Tekeli; J Sedef Gocmen; Derya Aysev; Haluk Guriz
Journal:  APMIS       Date:  2002-05       Impact factor: 3.205

7.  Shifting patterns in the epidemiology of nosocomial Candida infections.

Authors:  David R Snydman
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

8.  Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital.

Authors:  Nur Yapar; Ulker Uysal; Mine Yucesoy; Nedim Cakir; Ayse Yuce
Journal:  Mycoses       Date:  2006-03       Impact factor: 4.377

9.  [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].

Authors:  Fatih Erdem; Günay Tuncer Ertem; Behiç Oral; Esra Karakoç; Ali Pekcan Demiröz; Necla Tülek
Journal:  Mikrobiyol Bul       Date:  2012-10       Impact factor: 0.622

10.  Epidemiological trends in nosocomial candidemia in intensive care.

Authors:  Matteo Bassetti; Elda Righi; Alessandro Costa; Roberta Fasce; Maria Pia Molinari; Raffaella Rosso; Franco Bobbio Pallavicini; Claudio Viscoli
Journal:  BMC Infect Dis       Date:  2006-02-10       Impact factor: 3.090

View more
  2 in total

Review 1.  Sepsis and Septic Shock: Current Treatment Strategies and New Approaches.

Authors:  Gizem Polat; Rustem Anil Ugan; Elif Cadirci; Zekai Halici
Journal:  Eurasian J Med       Date:  2017-02

2.  Cross-Sectional Study of Candidemia from Isfahan, Iran: Etiologic Agents, Predisposing Factors, and Antifungal Susceptibility Testing.

Authors:  Maryam Ranjbar-Mobarake; Jamileh Nowroozi; Parisa Badiee; Sayed Nassereddin Mostafavi; Rasoul Mohammadi
Journal:  J Res Med Sci       Date:  2021-11-29       Impact factor: 1.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.